Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.
about
Structural basis of alpha-fucosidase inhibition by iminocyclitols with K(i) values in the micro- to picomolar rangeMiglitol: assessment of its role in the treatment of patients with diabetes mellitus.Metformin combined with acarbose vs. single medicine in the treatment of type 2 diabetes: A meta-analysisImproving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?The role of blood glucose-lowering drugs in the light of the UKPDS. United Kingdom Prospective Diabetes Study.Cardiovascular risk in type 2 diabetes.Miglitol, a new alpha-glucosidase inhibitor.Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian.A sensitive and selective method for the quantitative analysis of miglitol in rat plasma using unique solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry.D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independentMetathesis access to monocyclic iminocyclitol-based therapeutic agents.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.Xanthones from Swertia mussotii as multitarget-directed antidiabetic agents.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.The first synthesis of substituted azepanes mimicking monosaccharides: a new class of potent glycosidase inhibitors.Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis.New 1,2,3-Triazole Iminosugars Derivatives Using Click Chemistry
P2860
Q27658488-6FE11254-86C9-44BB-9811-75E9A8EF9362Q33422586-3665BCCB-55B4-411B-BEA4-F1F54C6B2BB7Q33744996-5C8DCB22-788B-404C-9152-BD05B91B2375Q33972782-F37C2416-18B2-4674-9BAC-02906412348EQ34024099-70A12409-4B6A-4BBF-863F-8802C04567D0Q34164112-42EE7A9E-79AD-4DC7-A7C3-EFB66F22002CQ34164119-920EB535-70A1-4F75-8D00-394B6587D683Q34182312-A2128511-BFC8-4AC0-A907-FBC84B5768EAQ34292429-308CF853-7672-49F3-AB14-C1CB92EDBC82Q34534466-1F60DB58-4ACE-4C93-9FA4-535FB87025F0Q35043812-2CF1BD60-54DA-4E1D-9DB2-F6E17B4A1D6CQ35140613-73BC4290-DAC0-4ACB-866F-826E261ABC9DQ36121785-12959331-1BAC-470B-9991-8336352B740EQ37909033-E4E782AA-E6BF-42CD-980B-61BD30F31446Q38563239-BC8D3E0A-EB0A-4C52-B22F-9C8C592C0543Q39028596-AAAF0F8E-12E2-4D80-A3AD-7A7F5761FF44Q39420555-FFDD67FF-C0C2-44F2-A1F2-5CA638AEEB22Q40332920-19F56C37-262C-48DC-8201-EB4DD4A19C31Q44891327-1760E9D5-9DD0-45B8-A27E-90952B195841Q47764756-012EF0ED-BCDE-4EC9-978B-95895613CE4CQ58703026-C244C80B-531B-4BB0-A5E1-654200CAAAF5
P2860
Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Long-term effectiveness of a n ...... ated type 2 diabetes mellitus.
@ast
Long-term effectiveness of a n ...... ated type 2 diabetes mellitus.
@en
type
label
Long-term effectiveness of a n ...... ated type 2 diabetes mellitus.
@ast
Long-term effectiveness of a n ...... ated type 2 diabetes mellitus.
@en
prefLabel
Long-term effectiveness of a n ...... ated type 2 diabetes mellitus.
@ast
Long-term effectiveness of a n ...... ated type 2 diabetes mellitus.
@en
P2093
P1433
P1476
Long-term effectiveness of a n ...... ated type 2 diabetes mellitus.
@en
P2093
P304
P356
10.1002/(SICI)1096-9136(199808)15:8<657::AID-DIA652>3.0.CO;2-7
P577
1998-08-01T00:00:00Z